The treatment of epilepsy in autism.

Hayes (1991) wrote a narrative review about treating epilepsy in children with autism.

The paper pulled together early case reports and small studies. It gave doctors cautious dosing tips and told them to track every seizure.

The review found almost no solid data. The author warned that most seizure drugs had never been tested in autistic kids.

Clinicians were told to start low, go slow, and watch for odd side effects.

Hirota et al. (2014) later ran a formal meta-analysis of seven tiny trials. They found antiepileptic drugs did not beat placebo for irritability or overall autism symptoms. This stronger evidence supersedes the 1991 guess-work.

Parsons et al. (2013) widened the lens to all psychotropics in autism. Like Hayes (1991), they still saw thin long-term data, showing the gap lasted decades.

Dawson et al. (2000) shifted focus to hyperactivity meds. Their review found some drugs helped attention, but again noted small, weak studies—echoing the 1991 call for better research.

You may meet parents hoping seizure medicine will also calm autism behaviors. Tell them the best data so far show no extra benefit for irritability or global symptoms. Stick to tracking seizures, start one drug at a time, and log every change. Share the Hirota et al. (2014) summary with prescribers so everyone bases choices on evidence, not old anecdotes.